Base care group:Citicoline sodium injection, intravenous drip: 0.25g a day

2 trials

Sponsors

Yunnan Third People's Hospital

Conditions

Acute cerebral infarction

Phase 4

Homocysteine, inflammatory factors, safety study of scutellarin for injection in patients with acute cerebral infarction - a single center, randomized, open label clinical trial

Active, not recruitingChiCTR2100048583

Yunnan Third People's HospitalAcute cerebral infarction

Start: 2021-07-19Updated: 2022-03-21

Homocysteine, inflammatory factors, safety study of scutellarin for injection in patients with acute cerebral infarction - a single center, randomized, open label clinical trial

Active, not recruitingITMCTR2100005042

Yunnan Third People's HospitalAcute cerebral infarction

Start: 2021-07-19Updated: 2023-02-20